Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07281690 · ClinicalTrials.gov registry record · Phase 3
Enhancing Skin Rejuvenation Using Laser and Exosomes
A Phase 3 study of Exosomes and Laser Therapy, sponsored by Laser Beamer Skincare.
- Completed
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07281690 is a Phase 3 study of Exosomes and Laser Therapy that has completed, run by Laser Beamer Skincare. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07281690, a Phase 3 study of Exosomes and Laser Therapy, has completed, sponsored by Laser Beamer Skincare.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Enhancing Skin Rejuvenation A Single-Blind, Randomized Control Study on the Combined Efficacy of Aerolase 1064 nm YAG Laser and Exosomes Derived from Umbilical Cord Mesenchymal Stem Cells
Conditions Studied
Interventions
- DEVICE 1064-nm Nd:YAG Laser Treatment
- BIOLOGICAL Topical Umbilical Cord-Derived Exosomes (UC-MSC Exosomes)
Study Locations (1)
Kansas
- LaserBeamerSkincare - Wichita
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2025-07-17 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07281690
The ClinicalTrials.gov registry entry for NCT07281690 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Laser Beamer Skincare, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Exosomes appearing as the primary indexed condition, and to 2 interventions - of which 1064-nm Nd:YAG Laser Treatment is the first listed.
NCT07281690 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT07281690 about?
NCT07281690 is a clinical study titled "Enhancing Skin Rejuvenation Using Laser and Exosomes". Enhancing Skin Rejuvenation A Single-Blind, Randomized Control Study on the Combined Efficacy of Aerolase 1064 nm YAG Laser and Exosomes Derived from Umbilical Cord Mesenchymal Stem Cells
What is the current status of trial NCT07281690?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2025-03-01. Estimated completion is 2025-07-17.
What conditions does trial NCT07281690 study?
This clinical trial studies the following conditions: Exosomes, Laser Therapy.
What interventions are being tested in trial NCT07281690?
The interventions under investigation include: 1064-nm Nd:YAG Laser Treatment (DEVICE), Topical Umbilical Cord-Derived Exosomes (UC-MSC Exosomes) (BIOLOGICAL).
Who is sponsoring clinical trial NCT07281690?
This trial is sponsored by Laser Beamer Skincare, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07281690 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Exosomes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.